Cargando…
个体化治疗时代多靶点药物究竟何去何从——多靶点药物治疗非小细胞肺癌最新临床进展综述
Multi-targeted tyrosine kinase inhibitors (TKIs) play important roles in the treatment of non-small cell lung cancer (NSCLC). Recently, results of several large phase Ⅲ studies have been published, showing bittersweet efficacy of multi-targeted TKIs. In the era of personalized therapy, optimal use o...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999997/ https://www.ncbi.nlm.nih.gov/pubmed/22104223 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.11.08 |